Imagine a world where ultrasound imaging is no longer confined to hospitals; patients with chronic conditions, such as hypertension and heart failure, could be monitored continuously in real time at home or on the move, giving healthcare practitioners ongoing clinical insights instead of the occasional snapshots – a scan here and a check-up there. This shift from reactive, hospital-based care to preventative, community and home-based care could enable earlier detection and timely intervention, and truly personalised care.
Bringing this vision to reality, the Singapore-MIT Alliance for Research and Technology (SMART), Massachusetts Institute of Technology’s (MIT) research enterprise in Singapore, has launched a new collaborative research project – Wearable Imaging for Transforming Elderly Care (WITEC).
WITEC marks a pioneering effort in wearable technology, medical imaging, research and materials science. It is Singapore’s first centre dedicated to foundational research and development of the world’s first wearable ultrasound imaging system capable of 48-hour intermittent cardiovascular imaging for continuous and real-time monitoring and diagnosis of chronic conditions such as hypertension and heart failure.
This multi-million dollar, multi-year initiative, supported by the National Research Foundation (NRF) Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme, brings together top researchers and expertise from MIT, Nanyang Technological University (NTU Singapore) and the National University of Singapore (NUS). Tan Tock Seng Hospital (TTSH) is WITEC’s clinical collaborator and will conduct patient trials to validate long-term heart imaging for chronic cardiovascular disease management.
“Addressing society’s most pressing challenges requires innovative, interdisciplinary thinking. Building on SMART’s long legacy in Singapore as a hub for research and innovation, WITEC will harness interdisciplinary expertise – from MIT and leading institutions in Singapore – to advance transformative research that creates real-world impact and benefits Singapore, the US and societies all over. This is the kind of collaborative research that not only pushes the boundaries of knowledge, but also redefines what is possible for the future of healthcare,” said Bruce Tidor, Chief Executive Officer and Director (Interim), SMART.
Industry-leading precision equipment and capabilities
To support this work, WITEC’s laboratory is equipped with advanced tools, including Southeast Asia’s first Nanoscribe Quantum X sub-micrometre 3D printer and the latest Verasonics Vantage NXT 256 ultrasonic imaging system, which is the first unit of its kind in Singapore.
Unlike conventional 3D printers that operate at millimetre or micrometre scales, WITEC’s 3D printer can achieve sub‑micrometre resolution, allowing components to be fabricated at the level of single cells or tissue structures. With this capability, WITEC researchers can prototype bioadhesive materials and device interfaces with unprecedented accuracy — essential to ensuring skin‑safe adhesion and stable, long‑term imaging quality.
